- Home
- TROW vs GH Comparison
TROW vs GH Comparison
Compare TROW & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TROW | GH |
|---|---|---|
| Founded | 1937 | 2011 |
| Country | United States | United States |
| Employees | 4802 | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.1B | 22.9B |
| IPO Year | 2000 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TROW | GH |
|---|---|---|
| Price | $109.56 | $162.14 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 11 | 19 |
| Target Price | $98.00 | ★ $119.79 |
| AVG Volume (30 Days) | 1.4M | ★ 1.8M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.18% | N/A |
| EPS Growth | 0.98 | ★ 6.74 |
| EPS | ★ 5.10 | N/A |
| Revenue | ★ $2,370,700,000.00 | $982,021,000.00 |
| Revenue This Year | $5.48 | $33.30 |
| Revenue Next Year | $1.56 | $28.27 |
| P/E Ratio | $21.37 | ★ N/A |
| Revenue Growth | 26.65 | ★ 32.88 |
| 52 Week Low | $85.22 | $53.40 |
| 52 Week High | $122.00 | $176.58 |
Technical Indicators
Market Signals| Indicator | TROW | GH |
|---|---|---|
| Relative Strength Index (RSI) | 39.38 | 50.86 |
| Support Level | $101.55 | $153.82 |
| Resistance Level | $110.15 | $173.94 |
| Average True Range (ATR) | 1.94 | 7.50 |
| MACD | -0.22 | -0.91 |
| Stochastic Oscillator | 19.17 | 38.61 |
Price Performance
Historical ComparisonAbout TROW T. Rowe Price Group Inc.
T. Rowe Price provides asset management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of May 2026, the firm had $1.892 trillion in managed assets, composed of equity (49%), balanced (37%), fixed-income and money market (11%), and alternative (3%) offerings. Approximately two-thirds of managed assets are held in retirement-based accounts, which provide T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.